Maia Biotechnology Stock Price Prediction
| MAIA Stock | USD 2.39 0.39 14.03% |
Momentum 60
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.74) | EPS Estimate Next Year (0.69) | Wall Street Target Price 12.135 | EPS Estimate Current Quarter (0.19) |
Using MAIA Biotechnology hype-based prediction, you can estimate the value of MAIA Biotechnology from the perspective of MAIA Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
MAIA Biotechnology Hype to Price Pattern
Investor biases related to MAIA Biotechnology's public news can be used to forecast risks associated with an investment in MAIA. The trend in average sentiment can be used to explain how an investor holding MAIA can time the market purely based on public headlines and social activities around MAIA Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of MAIA Biotechnology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about MAIA Biotechnology.
The fear of missing out, i.e., FOMO, can cause potential investors in MAIA Biotechnology to buy its stock at a price that has no basis in reality. In that case, they are not buying MAIA because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MAIA Biotechnology after-hype prediction price | USD 2.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out MAIA Biotechnology Basic Forecasting Models to cross-verify your projections. MAIA Biotechnology After-Hype Price Density Analysis
As far as predicting the price of MAIA Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MAIA Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MAIA Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MAIA Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting MAIA Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MAIA Biotechnology's historical news coverage. MAIA Biotechnology's after-hype downside and upside margins for the prediction period are 0.14 and 10.20, respectively. We have considered MAIA Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MAIA Biotechnology is very risky at this time. Analysis and calculation of next after-hype price of MAIA Biotechnology is based on 3 months time horizon.
MAIA Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as MAIA Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MAIA Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MAIA Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.36 | 7.60 | 0.01 | 0.02 | 11 Events / Month | 7 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.39 | 2.80 | 0.72 |
|
MAIA Biotechnology Hype Timeline
MAIA Biotechnology is now traded for 2.39. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.02. MAIA is forecasted to increase in value after the next headline, with the price projected to jump to 2.8 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is forecasted to be 0.72%, whereas the daily expected return is now at 1.36%. The volatility of related hype on MAIA Biotechnology is about 47500.0%, with the expected price after the next announcement by competition of 2.37. Net Loss for the year was (23.25 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 11 days. Check out MAIA Biotechnology Basic Forecasting Models to cross-verify your projections.MAIA Biotechnology Related Hype Analysis
Having access to credible news sources related to MAIA Biotechnology's direct competition is more important than ever and may enhance your ability to predict MAIA Biotechnology's future price movements. Getting to know how MAIA Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MAIA Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ELUT | Elutia Inc | 0.04 | 6 per month | 4.97 | 0.05 | 9.52 | (7.27) | 33.48 | |
| LTRN | Lantern Pharma | (0.13) | 8 per month | 0.00 | (0.04) | 10.27 | (5.57) | 23.91 | |
| BCAB | Bioatla | (0.03) | 9 per month | 0.00 | (0.11) | 15.28 | (16.25) | 54.11 | |
| PYPD | PolyPid | 0.13 | 10 per month | 1.70 | 0.18 | 4.79 | (3.95) | 13.02 | |
| RNXT | RenovoRx | (0.01) | 10 per month | 0.00 | (0.05) | 9.90 | (7.08) | 32.58 | |
| ANVS | Annovis Bio | (0.18) | 9 per month | 5.23 | 0.11 | 14.79 | (9.57) | 41.06 | |
| VERU | Veru Inc | (0.04) | 9 per month | 0.00 | (0.12) | 6.07 | (8.06) | 17.23 | |
| TVRD | Tvardi Therapeutics | 0.1 | 8 per month | 0.00 | (0.11) | 5.59 | (5.80) | 17.33 | |
| CELU | Celularity | (0.03) | 9 per month | 0.00 | (0.12) | 9.01 | (8.97) | 26.97 | |
| CALC | CalciMedica Common Stock | (0.01) | 35 per month | 0.00 | (0.02) | 12.74 | (7.69) | 40.42 |
MAIA Biotechnology Additional Predictive Modules
Most predictive techniques to examine MAIA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MAIA using various technical indicators. When you analyze MAIA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MAIA Biotechnology Predictive Indicators
The successful prediction of MAIA Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MAIA Biotechnology, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MAIA Biotechnology based on analysis of MAIA Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MAIA Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MAIA Biotechnology's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 1.53 | 2.65 | 3.05 | 3.27 | Net Debt To EBITDA | 0.36 | 0.41 | 0.47 | 0.65 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for MAIA Stock analysis
When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities |